$VICL Up to date company activities and other impo
Post# of 5326
Posted On: 12/10/2013 3:10:48 PM
$VICL Up to date company activities and other important information about $VICL
$VICL
DD Notes ~ http://www.ddnotesmaker.com/VICL
##### recent news/filings ~ source: finance.yahoo.com
Tue, 10 Dec 2013 14:49:50 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, IL & SAN DIEGO-December 10, 2013-Astellas Pharma Global Development, Inc.,a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Vical Incorporated (Nasdaq: VICL) today announced ...
read full: http://www.noodls.com/view/1EB79002E431BBB9C5...27F1045FA8
*********************************************************
Tue, 10 Dec 2013 12:00:00 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), and Vical Incorporated (VICL) today announced the initiation of a Phase 2 trial of ASP0113 in approximately 140 solid organ transplant (SOT) recipients. The global, randomized, double-blind, placebo-controlled trial is designed to evaluate the efficacy of ASP0113 compared to placebo as measured by the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. "Following the initiation of our Phase 3 trial of ASP0113 in hematopoietic cell transplant (HCT) recipients in June, we are pleased to expand the ASP0113 program with this Phase 2 trial in SOT recipients," said Bernie Zeiher, Senior Vice President and Global Therapeutic Area Head of Immunology and Infectious Diseases at Astellas Pharma Global Development, Inc. "The unmet medical need to control CMV in transplant recipients remains high."
read full: http://finance.yahoo.com/news/astellas-vical-...00689.html
*********************************************************
Sat, 07 Dec 2013 01:32:00 GMT ~ Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Vical Incorporated
- Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Vical Incorporated concerning possible violations of federal securities laws.
read full: http://finance.yahoo.com/news/law-offices-how...00537.html
*********************************************************
Thu, 05 Dec 2013 23:29:00 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Vical Incorporated to Contact Brower Piven Before the December 31, 2013 Lead Plaintiff Deadline
- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on beh
read full: http://finance.yahoo.com/news/shareholder-ale...00619.html
*********************************************************
Wed, 27 Nov 2013 22:01:00 GMT ~ SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Vical Incorporated and Certain Officers - VICL
- NEW YORK, Nov. 27, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Vical Incorporated ("Vical" or the "Company") (VICL) and certain of its officers. The class action, filed in United States District Court, Southern District of California, and docketed under 13-cv-02653, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Vical between February 8, 2012 and August 12, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. If you are a shareholder who purchased Vical securities during the Class Period, you have until December 31, 2013 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237.
read full: http://finance.yahoo.com/news/shareholder-ale...00735.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=VICL&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=VICL&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VICL/company-info
Ticker: $VICL
OTC Market Place: Not Available
CIK code: 0000819050
Company name: Vical Inc.
Company website: http://www.vical.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/VICL/filings
Latest financials: http://www.otcmarkets.com/stock/VICL/financials
Latest news: http://www.otcmarkets.com/stock/VICL/news - http://finance.yahoo.com/q/h?s=VICL+Headlines
Major holdings: http://data.cnbc.com/quotes/VICL/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=VICL+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/VICL.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=VICL
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Vical+Inc.&x=1...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Vical+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.vical.com
Alexa: http://www.alexa.com/siteinfo/http://www.vical.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.vical.com
http://www.pennystocktweets.com/stocks/profile/VICL
##### last known share structure ~ source: otcmarkets.com
Market Value: $118,017,204 a/o Dec 09, 2013
Shares Outstanding: 86,777,356 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/VICL
$VICL
DD Notes ~ http://www.ddnotesmaker.com/VICL
##### recent news/filings ~ source: finance.yahoo.com
Tue, 10 Dec 2013 14:49:50 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, IL & SAN DIEGO-December 10, 2013-Astellas Pharma Global Development, Inc.,a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Vical Incorporated (Nasdaq: VICL) today announced ...
read full: http://www.noodls.com/view/1EB79002E431BBB9C5...27F1045FA8
*********************************************************
Tue, 10 Dec 2013 12:00:00 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), and Vical Incorporated (VICL) today announced the initiation of a Phase 2 trial of ASP0113 in approximately 140 solid organ transplant (SOT) recipients. The global, randomized, double-blind, placebo-controlled trial is designed to evaluate the efficacy of ASP0113 compared to placebo as measured by the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. "Following the initiation of our Phase 3 trial of ASP0113 in hematopoietic cell transplant (HCT) recipients in June, we are pleased to expand the ASP0113 program with this Phase 2 trial in SOT recipients," said Bernie Zeiher, Senior Vice President and Global Therapeutic Area Head of Immunology and Infectious Diseases at Astellas Pharma Global Development, Inc. "The unmet medical need to control CMV in transplant recipients remains high."
read full: http://finance.yahoo.com/news/astellas-vical-...00689.html
*********************************************************
Sat, 07 Dec 2013 01:32:00 GMT ~ Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Vical Incorporated
- Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Vical Incorporated concerning possible violations of federal securities laws.
read full: http://finance.yahoo.com/news/law-offices-how...00537.html
*********************************************************
Thu, 05 Dec 2013 23:29:00 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Vical Incorporated to Contact Brower Piven Before the December 31, 2013 Lead Plaintiff Deadline
- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on beh
read full: http://finance.yahoo.com/news/shareholder-ale...00619.html
*********************************************************
Wed, 27 Nov 2013 22:01:00 GMT ~ SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Vical Incorporated and Certain Officers - VICL
- NEW YORK, Nov. 27, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Vical Incorporated ("Vical" or the "Company") (VICL) and certain of its officers. The class action, filed in United States District Court, Southern District of California, and docketed under 13-cv-02653, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Vical between February 8, 2012 and August 12, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. If you are a shareholder who purchased Vical securities during the Class Period, you have until December 31, 2013 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237.
read full: http://finance.yahoo.com/news/shareholder-ale...00735.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=VICL&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=VICL&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VICL/company-info
Ticker: $VICL
OTC Market Place: Not Available
CIK code: 0000819050
Company name: Vical Inc.
Company website: http://www.vical.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/VICL/filings
Latest financials: http://www.otcmarkets.com/stock/VICL/financials
Latest news: http://www.otcmarkets.com/stock/VICL/news - http://finance.yahoo.com/q/h?s=VICL+Headlines
Major holdings: http://data.cnbc.com/quotes/VICL/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=VICL+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/VICL.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=VICL
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Vical+Inc.&x=1...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Vical+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.vical.com
Alexa: http://www.alexa.com/siteinfo/http://www.vical.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.vical.com
http://www.pennystocktweets.com/stocks/profile/VICL
##### last known share structure ~ source: otcmarkets.com
Market Value: $118,017,204 a/o Dec 09, 2013
Shares Outstanding: 86,777,356 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/VICL
(0)
(0)